Home / News


Announging GenomeH, the first hybrid human whole genome sequencing test

Announging GenomeH, the first hybrid human whole genome sequencing test

Dante Labs announced its newest, in-house, sequencing test: GenomeH – the first hybrid whole genome sequencing test to leverage hybrid genome assembly and combine short and long reads sequencing in a single application, for superior coverage, accuracy and precision of the genome.

We announced today the launch of the most advanced and accurate whole genome sequencing test ever, the first one to leverage hybrid assembly at scale. The new test, named Whole GenomeH, provides a new genome assembly for each individual sequencing its genome, providing better alignment, superior detection of any type of variants, and better discoverability for the hard-to-reach regions of the DNA such as triplet expansions.

The hybrid genome GenomeH allows to expand the genetic conditions included in the study of the human whole genome.

“GenomeH is consistent with our mission to bridge the gap between science and everyday life in genomics,” Dante Labs CTO Mattia Capulli says. “Short reads and long reads together combine the benefits of the two technologies. The hybrid assembly is a synergy between two different ways to read the DNA, which compensate one another and dramatically enhance the understanding of the power of the genome.”

The test was developed in-house, in Dante Labs state-of-the-art European sequencing center, using both Illumina NovaSeq and Oxford Nanopore PromethION technologies.

“Today we are closer to the perfect world where all genetic tests will be based on whole genome sequencing,” Dante Labs CEO Andrea Riposati says. “The team worked hard in these past months to develop new approaches to sequencing and to train our algorithms to map short reads to long reads, outperforming any precision and accuracy level that we witnessed before. We are proud to offer this service just below $2,000 for the benefits of scientific research, medical practice, healthcare and individuals.”

The price of Whole GenomeH is $1,999 or €1,799.

Get your GenomeH

$189 Whole Genome Sequencing for Black Friday 2019

$189 Whole Genome Sequencing for Black Friday 2019
Dante Labs announced today the launch of its offer for 2019 Black Friday:
  • Premium 30X – 8 weeks turnaround time for €169/$189 and 
    2-weeks turnaround time for €549/$599
  • SuperPremium 30X+130X – 8 weeks turnaround time for €899/$899 and 
    2-weeks turnaround time for €999/$999

This offer is to highlights their ever-since mission: make advanced genetics accessible to everyone.

Genomics should not be a luxury! Andrea Riposati, CEO of Dante Labs, said.
In fact, thanks to their in-house ultra-advanced sequencing center in L’Aquila, Italy, the team at Dante Labs can optimize its work and increase the level of standardization for the entire workflow.

Also, to be honest to their clients, Dante Labs has decided to increase the turnaround time on the product page in case they reach their maximum sequencing capacity.

The products are available on the official website, by visiting the following specific page: 

EY Italy honored Dante Labs as Start-Up of the Year at 2019 EY Imprenditori Award Ceremony

EY Italy honored Dante Labs as Start-Up of the Year at 2019 EY Imprenditori Award Ceremony

MILAN — 21 November 2019 — At the 2019 EY Imprenditori Award Ceremony, leading DNA sequencing company Dante Labs has been recognized as Start-Up of the Year by Ernst & Young, the global leader in assurance, transaction and advisory services.

The recognition comes after an accurate evaluation by business experts.
Among the several criteria used by the jury to evaluate the candidates, Dante Labs exceeds for their business idea, especially for the strong impact they have on innovative research, and for their far-sighted vision to make advanced genomics accessible to everyone. By leveraging advanced data analysis algorithms and new DNA sequencing techniques, they offer personalized reports and continuous updates, making the genomics a service concept and implementing it in their new European sequencing center.

When they have been asked why they have chosen L’Aquila as the headquarter of Dante Labs, Andrea Riposati (Co-founder and CEO) and Mattia Capulli (Co-founder) said that it was not only for an emotional manner: “L’Aquila hosts one of the first biotechnology faculties of Italy and there are many relevant academic opportunities to collaborate with, such as Gran Sasso Science Institute. Moreover, Ciampino Airport is an important hub for DHL.”

The two friends started their company in 2016, and two years later they sequenced 8000 whole genomes, which is 2% of the samples sequenced in the world. Their goal is to reach 20.000 DNA samples sequenced in 2019.
A deserved reward for Dante Labs, also for the series of practices and work methodologies focused on the confidentiality in the data-processing. Dante Labs fully meets the GDPR rules, in order to protect the privacy of their customers.

As Luca Pellizzoni, EY partner and responsible of the EY Imprenditori Award, said: “This Award wants to recognize the Italian excellences.”
And Dante Labs, with business abilities, talents and great logistics found the perfect mix to be the best start-up in 2019.

The jury was presided by Gianni Mion, Edition President, and it was composed by Alberto Baban, entrepreneur; Paolo Boccardelli, director of LUISS Business School; Guido Corbetta, full professor in Corporate Strategy at Bocconi; Monica Mandelli, Managing Director in KKR & Co. in New York; Marco Nocivelli, president and CEO of Gruppo Epta; Cristina Scocchia, CEO of KIKO S.p.A.; Paolo Scudieri, CEO of Adler Plastic S.p.A.; Nunzio Tartaglia, responsible of CDP Imprese.

The 23rd Edition of EY Imprenditori Award was supported by Banca Akros (Gruppo Banco BPM) and Board International. The EY Start-Up Award was supported by P101.